Dalla Lana School of Public Health

Faculty Member

Chenxi Liu

Research Interests

My academic contribution has been focused on disease control and primary care in four areas: 1) digital health; 2) primary care capacity; 3) antimicrobial resistance (AMR); 4) health policy and economics evaluation. My research program has been strongly linked to creative professional activities to integrate implementation science and artificial intelligence to change clinical practices and health policies in China. Through my research, I have established close partnerships with health authorities, leading hospitals and academics in China. Evidence from my research has been used to inform national policies in China reimbursement drug list, control of antimicrobial resistance in primary care and COVID-19 among students. I have received roughly ￥825,000 externally funded peer-reviewed grants as PI and published 59 high-impact papers in NPJ primary care, Journal of Medical Internet Research, BMC Bioinformatics, Journal of global health, Antimicrobial Resistance & Infection Control.

I have proven records of impacts in teaching, capacity building and leadership. I designed and direct two courses in School of Medicine and Health Management (1 compulsory undergraduate and 1 elective postgraduate) and won first-class prize in faculty teaching competition in Huazhong University of Science Technology (HUST). I have supervised 14 postgraduate students (PhD and MSc). In School of Medicine and Health Management, HUST, I am Deputy Director of Department of Health Policy and Management (with 27 faculty). Globally, I have been an honorary lecturer of United Nations Institute for Training and Research (No. L2021-003). In China, I provide consultancy to National Healthcare Security Administration and National Medical Insurance Negotiations. I’m also the Deputy Secretary-General of Maternal and Child Public Health Committee, Chinese Medical Association.

Education

2013-2018	PhD, in School of Medicine and Heath Management, Huazhong University of Science and Technology, Wuhan, China
2016-2017	Government-sponsored exchange students, in School of Psychology and Public Health, La Trobe University, Australia
2009-2013	BPAPM, Huazhong University of Science and Technology, Hubei, China

 

Employment

Primary Academic Appointments

2026-2028	Associate Professor, Clinical Public Health Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
2025-	Associate Professor, Global Implementation Science Lab, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
2025-2026	Visiting Scholar, Clinical Public Health Division and Institute of Health Policy, Management & Evaluation, in Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
2023-	Associate Professor, School of Medicine and Health Management, Huazhong University of Science and Technology, Wuhan, China
2023-	Deputy Director of Department of Health Policy and Management, School of Medicine and Health Management, Huazhong University of Science and Technology, Wuhan, China
2021-	Research Fellow, National Healthcare Security Administration Institute, China – HUST Chapter

Executive positions in International and National Organizations

2022-

Deputy Secretary-General, Maternal and Child Public Health Committee of Chinese Medical Association

Awards

2022	First Price in Faculty Teaching Competition, Huazhong University of Science and Technology
2021	Honorary Lecturer, United Nations Institute for Training and Research (No. L2021-003)
2020	Best Poster Award, China Healthcare Management Annual Forum for Young Scholars
2019	Excellent Oral Presenter, China Healthcare Management Annual Forum for Young Scholars

 

Professional Activities

Consultations

2023-	Consultant Expert in pharmaco-economics, National Healthcare Security Administration, China
2023-	Consultant Expert, Smart Hospital Research Institute, Peking University Shenzhen Hospital
2024	Consultant Expert in pharmaco-economics evaluation panel, National Medical Insurance Negotiations, 2024, China

 

Professional Associations

2025-	Member of Pharmaceutical Economics Committee, China Health Insurance Research Association (CHIRA)
2025-	Member of Drug Policy Research Committee, China Association for Promotion of Health Science and Technology
2025-	Membership of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

 

External reviews for funding agencies

2020-

Reviewer, National Natural Science Foundation of China

 

Journal editorship and peer reviews

2024-	Associate Editor, Family Medicine and Community Health, BMJ publishing group
2024-	Associate Editor, Chinese General Practice, National Health Commission of China
2024-	Editor, Digital Health, Sage publishing group
2024-	Editor, Scientific Report, Nature publishing group
2018-	Peer reviewer for journals: Lancet-Planetary Health, Lancet-Regional Health, BMJ Mental Health, BMJ General Psychiatry, Implementation Science, Journal of Infection and Public Health, Antimicrobial Resistance and Infection Control, Expert Review of Anti-infective Therapy, Preventative Medicine, BMC Digital Health, BMC Health Services Research, BMC primary care, BMC Medical Education, Global Health Research and Policy, Health Policy and Technology, Research in Social and Administrative Pharmacy, Frontiers in Pharmacology, Plos One, BMJ-Open, Population and Development [Chinese], Medicine and Society [Chinese], Chinese General Practice [Chinese]

Publications

a. Papers published in peer-reviewed journals (chronological order)

Total: 58 papers, including 13 as the Principal Author (PA), 25 as Senior Responsible Author (SRA), and 21 as Co-Authors (CA)

Full publication: Web of Science Researcher ID: AAD-5168-2019

5-year impact factors used (based on May 2025)

Updated by Jul. 7, 2025

1.	Dec 2025	Jiang W, Wang D, Zeng Y, Huang J, Xu C, Liu C*; Promoting Responsible DeepSeek Deployment in Health Care: Scoping Review Comparing Grey and White Literature; J Med Internet Res 2025;27:e80770; doi: 10.2196/80770	SRA. IF:6.7 SCI-Q1
2.	Nov 2025	Zheng, J., Liu, Y., Wang, X., Li, H., & Liu, C*. (2025). Price composition analysis of blood glucose meters and blood glucose test strips in Hubei Province based on the World Health Organization/Health Action International standard survey method. Journal of Chinese Pharmaceutical Sciences, 34(10), 954.	SRA. CSCD.
3.	Jul 2025	Chenxi Liu; Jianing Zheng; Yushu Liu; Xi Wang; Yuting Zhang; Qiang Fu; Wenwen Yu; Ting Yu; Wang Jiang; Dan Wang; Chaojie Liu; Potential to Perpetuate Social Biases in Health Care by Chinese Large Language Models: A Model Evaluation Study. Int J Equity Health 24, 206 (2025). https://doi.org/10.1186/s12939-025-02581-5	PA. IF: 5.0 SSCI-Q1
4.	Jun 2025	Liu, Y., Liu, C.*, Zheng, J., Xu, C., & Wang, D. Improving explainability and integrability of medical artificial intelligence to promote healthcare professional acceptance and usage: A mixed systematic review. J Med Internet Res.	SRA. IF:6.7 SCI-Q1
5.	May 2025	Wang, X., Liu, C.*, Zheng, S*. et al. The public’s irrational use of antibiotics for upper respiratory tract infections: a cross-sectional study based on the health belief model. Sci Rep 15, 17220 (2025). https://doi.org/10.1038/s41598-025-01767-9	SRA. IF: 3.8 SCI-Q1
6.	Feb 2025	Liu C, Liu Y, Liu C, Lin R, Wang X, Zhang X, Wu Y, Wang D. The Moderated Mediating Effects of Social Media Identity and Loneliness on the Relationship Between Problematic Internet Use and Mental Health in China: Nationwide Cross-Sectional Questionnaire Study. J Med Internet Res 2025;27:e57907. DOI: 10.2196/57907	PA. IF: 6.7. SCI-Q1
7.	Dec 2024	Duan L, Lin R, Wang D, Wang X, Zhang X, Ding L*, Liu C*. Eliciting parents’ decision-making to antibiotic use for upper respiratory tract infections: A discrete choice experiment. J Glob Health. 2024 Dec 9;14:04220. doi: 10.7189/jogh.14.04220. PMID: 39651656.	SRA. IF: 5.3. SCI/SSCI-Q1
8.	Dec 2024	Liu C, Wang X, Zhang X, Liu Y, Lin R, Wu Y, Wang D. The impact of family climate on problematic internet use: Findings from one nationwide study in China. J Affect Disord. 2024 Dec 15;367:350-358. doi: 10.1016/j.jad.2024.09.010.	PA. IF: 5.4. SCI/SSCI-Q1
9.	Dec 2024	YANG Hui; WANG Yang; CHEN Qingqi; LIU Chenxi; GU Jie; ZHAO Yang; QIN Jiangmei; CAO Xinyang; Elizabeth Sturgiss; William R.Phillips; XU Yanli. Applying the Consensus Reporting Items for Studies in Primary Care Checklist to Improve Reporting Quality in Primary Care Research in China. Chinese General Practice. 2025,28(04):393-401. [in Chinese & English]	CA. Core Journals (PKU)
10.	Nov 2024	Xi Wang, Chenxi Liu*, Yibo Wu, Hongxia Gao. Study on the Influence of Individual, Family, and Social Factors on Fertility Intentions among the Reproductive-Age Population in China [in Chinese]	SRA. CSSCI
11.	Aug 2024	LIN Rujiao; LIU Chenxi*; DUAN Lixia; WANG Xi; ZHANG Xinyi; WANG Dan; ZHANG Xinping. Research progress on health information authority identification behavior among middle-aged and elderly patients with chronic diseases: a review Chinese Journal of Public Health. 2024, (08):937-942. [in Chinese]	SRA. CSCD
12.	Aug 2024	Liu Chenxi; Wang Qian; Yao Lan. Research on New-quality Productivity Empowers the Construction of Healthy China. Chinese Health Economics. 2024-08-07 15:21 [in Chinese & English]	PA. Core Journals (PKU)
13.	Feb 2024	Qi H, Yu T, Yu W, Liu C. Drug-target affinity prediction with extended graph learning-convolutional networks. BMC Bioinformatics. 2024 Feb 16;25(1):75. doi: 10.1186/s12859-024-05698-6.	CA. IF: 3.6. SCI-Q1
14.	Dec 2023	Lin R, Duan L, Liu C, Wang D, Zhang X, Wang X, Zhang X, Wang Q, Zheng S* and Liu C* (2023) The public’s antibiotic use behavioural patterns and their determinants for upper respiratory tract infections: a latent class analysis based on consumer behaviour model in China. Front. Public Health. 11:1231370. doi: 10.3389/fpubh.2023.1231370	SRA. IF: 3.6. SCI/SSCI-Q2
15.	Oct 2023	Chen M, Zhang X, Liu C, Chen H, Wang D and Liu C (2023) Effects of public reporting of prescription indicators on patient choices: evidence from propensity scores matching. Front. Pharmacol. 14:1110653. doi: 10.3389/fphar.2023.1110653	CA IF: 5. SCI-Q1
16.	Sep 2023	ZHANG Xinyi; WANG Xi; WANG Dan; DUAN Lixia; LIN Rujiao; LIU Chenxi*. The Potential Patterns of Symptoms of Upper Respiratory Tract Infections in the Public and Their Effects on Antibiotic Use Behavior. Chinese General Practice   . 2023-09-01 11:45. [in Chinese &English]	SRA. Core Journals (PKU)
17.	Aug 2023	Wang Q, Wu Y, Wang D, Lai X, Tan L, Zhou Q, Duan L, Lin R, Wang X, Zheng F, Yu T, Wang L, Fan S, Wang Y, Zhang X*, Liu C*. The impacts of knowledge and attitude on behavior of antibiotic use for the common cold among the public and identifying the critical behavioral stage: based on an expanding KAP model. BMC Public Health. 2023 Aug 31;23(1):1683. doi: 10.1186/s12889-023-16595-7.	SRA IF: 3.9 SCI-Q1
18.	Sep 2023	Shao Y, Hu H, Liang Y, Hong Y, Yu Y, Liu C*, Xu Y*. Health literacy interventions among patients with chronic diseases: A meta-analysis of randomized controlled trials. Patient Educ Couns. 2023 Sep; 114:107829. doi: 10.1016/j.pec.2023.107829.	SRA IF: 3.3 SCI/SSCI-Q1
19.	Jun 2023	Wang X, Liu C, Du Y, Wang D, Zhang X. Do Knowledge, Attitudes, and Barrier Perception Affect the Prevention and Control of Healthcare-Associated Infections? A Structural Equation Modelling Approach. Infect Drug Resist. 2023;16:3051-3063	CA IF: 3.6 SCI-Q2
20.	Apr 2023	Qian P, Duan L, Lin R, Du X, Wang D, Zeng T, Liu C*. Decision-making process of breastfeeding behavior in mothers with gestational diabetes mellitus based on health belief model. BMC Pregnancy Childbirth. 2023 Apr 12;23(1):242. doi: 10.1186/s12884-023-05527-3.	SRA IF: 3.4 SCI-Q1
21.	Apr 2023	Wang D, Sun X, He F, Liu C*, Wu Y*. The mediating effect of family health on the relationship between health literacy and mental health: A national cross-sectional survey in China. International Journal of Social Psychiatry. 2023;69(6):1490-1500. doi:10.1177/00207640231166628	SRA IF: 4.6 SSCI-Q2
22.	Apr 2023	Dan Wang, Meng Han, Lixia Duan, Rujiao Lin, Pan Qian, Xinping Zhang, Yuqing Tang, Chenxi Liu*. Rational antibiotics use-related behavior patterns and associates: a cross-sectional survey among Chinese community adults. Chinese Journal of Public Health. 2023-04-23. [in Chinese]	SRA. CSCD
23.	Oct 2022	Duan L, Liu C, Wang D, Lin R, Qian P, Zhang X, Liu C*. The vicious cycle of the public’s irrational use of antibiotics for upper respiratory tract infections: A mixed methods systematic review. Front Public Health. 2022 Oct 20;10:985188. doi: 10.3389/fpubh.2022.985188.	SRA IF: 3.6 SCI/SSCI-Q2
24.	Oct 2022	Qian P, Duan L, Lin R, Du X, Wang D, Liu C* and Zeng T* (2022) How breastfeeding behavior develops in women with gestational diabetes mellitus: A qualitative study based on health belief model in China. Front. Endocrinol. 13:955484. doi: 10.3389/fendo.2022.955484	SRA IF: 4.9 SCI-Q2
25.	Jul 2022	Hu H, Xu Y*, Shao Y, Liang Y, Wang Q, Luo S, Lu H, Meng H and Liu C* (2022) A latent profile analysis of residents’ knowledge, attitude, and practice toward common chronic diseases among ethnic minority area in China. Front. Public Health 10:940619. doi: 10.3389/fpubh.2022.940619	SRA IF: 3.6 SCI/SSCI-Q2
26.	May 2022	Lu J, Liu C, Wang D and Zhang X (2022) Influence of Work Values on the Prescribing Behavioral Intentions Regarding Antibiotic Use Among Primary Physicians in Hubei, China. Front. Public Health 10:830181. doi: 10.3389/fpubh.2022.830181	CA IF: 3.6 SCI/SSCI-Q2
27.	Feb 2022	DUAN Lixia; LIU Chenxi*; Changes in Knowledge and Attitudes towards Antibiotic Use among Primary Care Physicians in Hubei Province：a Propensity Score-matched Analysis. Chinese General Practice 2022-02-18 14:59 [in Chinese & English]	SRA Core Journals (PKU)
28.	Jan 2022	Wang D, Zhang X, Chen H* and Liu C* (2022) Applying Theory of Planned Behavior to Understand Physicians’ Shared Decision-Making With Patients With Acute Respiratory Infections in Primary Care: A Cross-Sectional Study. Front. Pharmacol. 12:785419. doi: 10.3389/fphar.2021.785419	SRA IF: 5 SCI-Q1
29.	Feb 2022	Peng X, Guo X, Li H, Wang D, Liu C and Du Y (2022) A Qualitative Exploration of Self-Management Behaviors and Influencing Factors in Patients With Type 2 Diabetes. Front. Endocrinol. 13:771293. doi: 10.3389/fendo.2022.771293	CA IF: 4.9 SCI-Q2
30.	Dec 2021	Liu C, Wang D, Duan L, Zhang X and Liu C* (2021) Coping with Diagnostic Uncertainty in Antibiotic Prescribing: A Latent Class Study of Primary Care Physicians in Hubei China. Front. Public Health 9:741345. doi: 10.3389/fpubh.2021.741345	SRA IF: 3.6 SCI/SSCI-Q2
31.	Aug 2021	Xie L, Du Y, Wang X, Zhang X, Liu C, Liu J, Peng X, Guo X. Effects of Regulation on Carbapenem Prescription in a Large Teaching Hospital in China: An Interrupted Time Series Analysis, 2016–2018. Infect Drug Resist. 2021;14:3099-3108 https://doi.org/10.2147/IDR.S322938	CA IF: 3.6 SCI-Q2
32.	May 2021	Duan L, Liu C*, Wang D. The General Population’s Inappropriate Behaviors and Misunderstanding of Antibiotic Use in China: A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2021 Apr 26;10(5):497. doi: 10.3390/antibiotics10050497.	SRA IF: 4.6 SCI-Q1
33.	May 2021	Duan Z, Liu C, Han M, Wang D, Zhang X, Liu C*. Understanding consumer behavior patterns in antibiotic usage for upper respiratory tract infections: A study protocol based on the COM-B framework. Res Social Adm Pharm. 2021 May;17(5):978-985. doi: 10.1016/j.sapharm.2020.07.033.	SRA IF: 3.3 SSCI-Q1
34.	Mar 2021	Wang D, Liu C, Zhang X, Liu C*. Does diagnostic uncertainty increase antibiotic prescribing in primary care? NPJ Prim Care Respir Med. 2021 Mar 25;31(1):17. doi: 10.1038/s41533-021-00229-9. PMID: 33767206; PMCID: PMC7994848.	SRA IF: 3.1 SCI-Q1
35.	Mar 2021	Wang D, Liu C, Liu C, Wang X, Zhang X. Improving pharmacist-patient communications based on King’s theory of goal attainment: Study protocol for a cluster randomized controlled trial. Res Social Adm Pharm. 2021 Mar;17(3):625-631. doi: 10.1016/j.sapharm.2020.05.013.	CA IF: 3.3 SSCI-Q1
36.	Dec 2020	Wang D, Liu C*, Wang X, Zhang X*. Association between Physicians’ Perception of Shared Decision Making with Antibiotic Prescribing Behavior in Primary Care in Hubei, China: A Cross-Sectional Study. Antibiotics (Basel). 2020 Dec 8;9(12):876. doi: 10.3390/antibiotics9120876.	SRA IF: 4.6 SCI-Q1
37.	Nov 2020	Wang D, Liu C, Zhang X and Liu C* (2020) Identifying Antibiotic Prescribing Patterns Through Multi-Level Latent Profile Analyses: A Cross-Sectional Survey of Primary Care Physicians. Front. Pharmacol. 11:591709. doi:10.3389/fphar.2020.591709	SRA IF: 5 SCI-Q1
38.	Sep 2020	Wang X, Tang Y, Liu C, Liu J, Cui Y, Zhang X. Effects of restrictive-prescribing stewardship on antibiotic consumption in primary care in China: an interrupted time series analysis, 2012-2017. Antimicrob Resist Infect Control. 2020 Sep 25;9(1):159. doi: 10.1186/s13756-020-00821-7.	CA IF: 5.8 SCI-Q1
39.	Sep 2020	Wang D, Liu C, Zhang X. Do Physicians’ Attitudes towards Patient-Centered Communication Promote Physicians’ Intention and Behavior of Involving Patients in Medical Decisions? Int J Environ Res Public Health. 2020 Sep 2;17(17):6393. doi: 10.3390/ijerph17176393.	CA IF: 4.8 SSCI-Q1
40.	Jun 2020	Lai X#, Wang X#, Yang Q#, Xu X#, Tang Y#, Liu C#, Tan L, Lai R, Wang H, Zhang X, Zhou Q, Chen H. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China? Antimicrob Resist Infect Control. 2020 Jun 11;9(1):83. doi: 10.1186/s13756-020-00746-1.	PA IF: 5.8 SCI-Q1
41.	Mar 2020	Liu C, Wang D, Liu C, Jiang J, Wang X, Chen H, Ju X, Zhang X. What is the meaning of health literacy? A systematic review and qualitative synthesis. Fam Med Community Health. 2020 May;8(2):e000351. doi: 10.1136/fmch-2020-000351.	PA IF: 5.9 ESCI-Q1
42.	May 2020	Chen H, Tang Y, Liu C, Liu J, Wang K, Zhang X. Adherence to drug therapy for hypertensive disorders of pregnancy: a cross-sectional survey. Arch Public Health. 2020 May 8;78:41. doi: 10.1186/s13690-020-00423-0.	CA IF: 3.3 SCI/SSCI-Q2
43.	Feb 2020	Wang X, Li F, Wang X, Zhang X, Liu C, Wang D, Wang H, Chen Y. Effects of different mark-up drug policies on drug-related expenditures in tertiary public hospitals: an interrupted time series study in Shanghai, China, 2015-2018. Biosci Trends. 2020 Mar 16;14(1):16-22. doi: 10.5582/bst.2019.01350.	CA IF: 3.9 SCI-Q1
44.	Jul 2019	Chen H, Liu C, Liu J, Tang Y, Zhang X. Mixed effects of restriction strategies in antimicrobial stewardship programs on antimicrobial use in 121 tertiary hospitals in China, 2013-2017. Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):483-489. doi: 10.1080/14737167.2018.1547635.	CA IF: 2.2 SCI/SSCI-Q3
45.	Jul 2019	Liu C, Liu C, Wang D, Zhang X. Knowledge, Attitudes and Intentions to Prescribe Antibiotics: A Structural Equation Modeling Study of Primary Care Institutions in Hubei, China. Int J Environ Res Public Health. 2019 Jul 5;16(13):2385. doi: 10.3390/ijerph16132385.	PA IF: 4.8 SSCI-Q1
46.	Aug 2019	Liu C, Liu C, Wang D, Zhang X. Intrinsic and external determinants of antibiotic prescribing: a multi-level path analysis of primary care prescriptions in Hubei, China. Antimicrob Resist Infect Control. 2019 Aug 7;8:132. doi: 10.1186/s13756-019-0592-5.	PA IF: 5.8 SCI-Q1
47.	Jan 2019	Liu C, Liu C, Wang D, Deng Z, Tang Y, Zhang X. Determinants of antibiotic prescribing behaviors of primary care physicians in Hubei of China: a structural equation model based on the theory of planned behavior. Antimicrob Resist Infect Control. 2019 Jan 30;8:23. doi: 10.1186/s13756-019-0478-6.	PA IF: 5.8 SCI-Q1
48.	Jan 2019	Wang D, Liu C, Zhang Z, Ye L, Zhang X. Validation of the King’s transaction process for healthcare provider-patient context in the pharmaceutical context. Res Social Adm Pharm. 2019 Jan;15(1):93-99. doi: 10.1016/j.sapharm.2018.03.063.	CA IF: 3.3 SSCI-Q1
49.	Dec 2018	Wang X, Du X, Liu C, Zhang X. Does the professional attitude of physicians always affect their professional behaviour? A survey in tertiary hospitals in Nanchang City, China. Aust Health Rev. 2018 Dec;42(6):650-655. doi: 10.1071/AH16190.	CA IF: 1.7 SCI-Q3
50.	Jul 2018	Liu J, Yin C, Liu C, Tang Y and Zhang X (2018) Modeling a Production Function to Evaluate the Effect of Medical Staffing on Antimicrobial Stewardship Performance in China, 2009–2016: Static and Dynamic Panel Data Analyses. Front. Pharmacol. 9:775. doi: 10.3389/fphar.2018.00775	CA IF: 5 SCI-Q1
51.	Jun 2018	Wang D, Liu C, Zhang Z, Ye L, Zhang X. Testing a healthcare provider-patient communicative relationship quality model of pharmaceutical care in hospitals. Int J Clin Pharm. 2018 Jun;40(3):617-626. doi: 10.1007/s11096-018-0618-8.	CA IF: 2.4 SCI-Q2
52.	Sep 2017	Tang Y, Liu C, Zhang X. Performance associated effect variations of public reporting in promoting antibiotic prescribing practice: a cluster randomized-controlled trial in primary healthcare settings. Primary Health Care Research & Development. 2017;18(5):482-491. doi:10.1017/S1463423617000329	CA IF: 2 SCI-Q3
53.	Dec 2017	Liu J, Wang L, Liu C, Zhang X. Impact of price deregulation policy on the affordability of essential medicines for women’s health: a panel data analysis. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):625-631. doi: 10.1080/14737167.2017.1330151.	CA IF: 2 SCI/SSCI-Q3
54.	Aug 2017	Liu C, Zhang X, Liu C, Ewen M, Zhang Z, Liu G. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China. BMC Health Serv Res. 2017 Aug 24;17(1):597. doi: 10.1186/s12913-017-2553-0.	PA IF: 3.1 SCI-Q2
55.	Jun 2017	Liu C, Tang Y, Wang D, Zhang X. The effect of public reporting presentation on patients’ decision making: An experimental survey in Yunan Province, China. Medicine (Baltimore). 2017 Jun;96(24):e7203. doi: 10.1097/MD.0000000000007203.	PA IF: 1.6 SCI-Q2
56.	Jun 2016	Liu C, Zhang X, Wang X, Zhang X, Wan J, Zhong F. Does public reporting influence antibiotic and injection prescribing to all patients? A cluster-randomized matched-pair trial in china. Medicine (Baltimore). 2016 Jun;95(26):e3965. doi: 10.1097/MD.0000000000003965.	PA IF: 1.6 SCI-Q2
57.	Oct 2015	Wang D, Lai X, Liu C, Xiong Y, Zhang X. Influence of supplemental parenteral nutrition approach on nosocomial infection in pediatric intensive care unit of Emergency Department: a retrospective study. Nutr J. 2015 Oct 6;14:103. doi: 10.1186/s12937-015-0094-0.	CA IF: 4.6 SCI-Q1
58.	Aug 2015	Liu C, Zhang X, Wan J. Public reporting influences antibiotic and injection prescription in primary care: a segmented regression analysis. J Eval Clin Pract. 2015 Aug;21(4):597-603. doi: 10.1111/jep.12343.	PA IF: 2.5 SCI-Q2
59.	Dec 2014	Zhong F, Liu C, Zhang X. Guideline adherence for the treatment of advanced schistosomiasis japonica in Hubei, China. Parasitol Res. 2014 Dec;113(12):4535-41. doi: 10.1007/s00436-014-4143-y.	CA IF: 1.9 SCI-Q3

 

b.Conference presentations: keynote and invited speeches, abstracts (chronological order)

1.	Chenxi Liu (2025), Potential to Perpetuate Social Biases in Health Care by Chinese Large Language Models: A Model Evaluation Study. China Health Policy and Management Society 2025. Annual Conference, online. 08.10.
2.	Chenxi Liu (2025), Potential to Perpetuate Social Biases in Health Care by Chinese Large Language Models: A Model Evaluation Study, China Health Policy and Management Society 2025 Annual Conference, online. 08.10.
3.	Chenxi Liu (2025), Pharmacoeconomic Evaluation of Dantrolene Sodium Capsules in the Treatment of Spasticity and Malignant Hyperthermia, Health Insurance Access Policies for Innovative Drugs Seminar, online. 07.30.
4.	Chenxi Liu (2025), Perspectives and Methods to Analyse Drug Utilization Surveillance Data: A Case Study of Antidiabetic medicine in Hube Province, Training Program of Hubei Health Commission, online. 05.20.
5.	Chenxi Liu (2024), Standardized Use of Medication Records to Improve the Quality of Pharmaceutical Services, The 3rd Luojia Pharmaceutical Forum, Wuhan, China. 11.30
6.	Chenxi Liu (2024), Supporting Policies for the Coordination of Essential Medicine Use Between Different Levels of Medical Institutions, The 3rd Luojia Pharmaceutical Forum, Wuhan, China. 11.30.
7.	Chenxi Liu (2024), Value-Based Pharmacoeconomic Evaluation: Current Status and Progress, The 3rd China Conference on Health Economics and Medical Insurance, Haikou, China. 05.18.
8.	Chenxi Liu (2024). Methods and Practices for Analyzing Drug Utilization Surveillance Data in Medical Institutions, Policy Training Program of Health Commission of Xinjiang Uygur Autonomous Region, Urumqi, China. 04.17
9.	Chenxi Liu (2024). Current Status and Coordination of Antidiabetic Drug Use Across Medical Institutions at All Levels in Hubei Province. National Health Commission Conference on Drug Utilization Surveillance, Chongqing, China. 02.26.
10.	Chenxi Liu (2023). Current Status and Coordination of Antidiabetic Drug Use Across Medical Institutions at All Levels in Hubei Province. Symposium on Drug Utilization Surveillance of National Health Commission, Beijing, China. 12.20.
11.	Chenxi Liu (2023). Causal Inference and Influencing Factors: Current Status and Challenges. Dongying People’s Hospital, Dong Ying, China. 11.21.
12.	Chenxi Liu (2023). Causal Inference and Research on Influencing Factors: Current Status and Challenges, Youth Academic Annual Conference of Health Policy and Management Branch Hubei Preventive Medicine Association, Wuhan, China. 10.28.
13.	Chenxi Liu (2023). The Pharmacoeconomic Evaluation of Dantrolene Sodium Capsules. Symposium of Reimbursement Policies for Innovative Drugs. Wuhan, China. 08.13.
14.	Chenxi Liu (2023). The Theory and Practice of the National Essential Medicines System. Training Conference of the Hubei Provincial Health Commission. Wuhan, China. 06.27
15.	Chenxi Liu (2021-2022). The Application of Information Technology in Management of Public Health: based on the Case of Prevention and Control of COVID-19 in China, CIFAL Shanghai International Training Centre affiliated to the UNITAR. Online. 6 times covering 27 countries and over 200 officials in health department, 2022.09.22; 07.11; 2021. 09.01; 09.10; 09.28; 10.28.
16.	Chenxi Liu (2022). Decision-Making Pathways and Behavioural Patterns of Irrational Antibiotic Use for Upper Respiratory Tract Infections Among the Public. 2022 Symposium on Drug Utilization Research, Shanghai, China. 10.30.
17.	Chenxi Liu (2022). Knowledge and Attitudes of Healthcare Workers toward Antimicrobial Use in Primary Healthcare Institutions. Talents Cultivation Program of National Health Commission’s Institute of Hospital Management. Online. 09.02
18.	Chenxi Liu (2022). Research on a Value-Based Medical Insurance Payment System, Symposium on Medical Insurance Payment Systems. Wuhan, China. 05.15.
19.	Chenxi Liu (2021). The Impact of Diagnostic Uncertainty on Physicians’ Antibiotic Prescribing: A Study in Primary Healthcare Institutions Based on Three Major Respiratory Diseases. Researcher Interview from Family Medicine and Community Health. Online. 10.20.
20.	Chenxi Liu (2021). Article and Project Proposal Drafting. Training Program on Pharmaceutical Service Competency for Pharmacists in Primary Hospitals. Online. 10.10
21.	Chenxi Liu (2021). Coping with diagnostic uncertainty in antibiotic prescribing: a latent class study of primary care physicians in Hubei, China. Annual Conference of the Chinese Society of Health Policy and Management. Online. 07.18.
22.	Chenxi Liu (2020). Mechanisms of Antibiotic Prescribing Behaviour among Primary Healthcare Physicians. China Action to Curb Antimicrobial Resistance — AMR & Social Science Academic Conference. Hangzhou, China. 11.19.
23.	Chenxi Liu (2020). Effect of Diagnostic Uncertainty on Physicians’ Antibiotic Prescribing: Primary Healthcare Context based on Three Respiratory Diseases. Drug Utilization Research 2020 Seminar. Shanghai, China. 10.25.
24.	Chenxi Liu (2020). Coping with Diagnostic Uncertainty in Antibiotic Prescribing: A Latent Class Study of Primary Care Physicians in Hubei, China. 2020 Young Scholars Forum on Health Policy and Management. Xi’an, China. 10.17
25.	Chenxi Liu (2019). Intrinsic and external determinants of antibiotic prescribing: a multi-level path analysis of primary care prescriptions in Hubei, China. 2019 Young Scholars Forum on Health Policy and Management. Chengdu, China. 10.19
26.	Chenxi Liu (2019) Antibiotic Prescribing Behaviour of Primary Healthcare Doctors: A Series of Studies Based on Primary Healthcare, Hubei Province. Sino-Dutch antibiotic use and AMR control forum. 10.14.

 

c. Book, book chapters and reports

(chronological order)

1.	Chenxi Liu. Overview of China’s Health System (Chapter 1) & China’s Medical Service System (Chapter 3), China’s Health System. Springer & Huazhong University of Science and Technology Press. ISBN: 978-981-95-1205-8. 2025.
2.	Chenxi Liu, Xinping Zhang. Drug Utilization Research and Management (Chapter 12), Pharmaceutical Policy and Management. People’s medical publishing house Co., Ltd. ISBN: 978-7-1173-5588-9. 2023.
3.	Hongbing Tao, Yingyao Chen, Chenxi Liu, et al. Casebook of Hospital Management and Service Innovation. Peking Union Medical College Press. ISBN: 978-7-5679-2335-5. 2023.
4.	Chenxi Liu, Xinping Zhang. Global Governance Model for Antimicrobial Resistance and Its Implications for China. Huazhong University of Science and Technology Press. ISBN: 978-7-2350-7359-2. 2022.
5.	Chenxi Liu, Hongbing Tao, Bo Shen. How to Write a Research Proposal (Chapter 6), Literature Review and Research Proposal. Peking Union Medical College Press. ISBN: 978-7-5679-1923-5. 2022.
6.	Hongbing Tao, Chenxi Liu. Recommendations for Containment and Prevention of the SARS-CoV-2 Lambda Variant, National Ministry of Education of China. 2022
7.	Xinping Zhang, Chenxi Liu, Yingchun Chen. Precision Monitoring Model for Rational Antibiotic Use in Primary Healthcare, Hubei Government. 2021.